Insulin Delivery System Market: Global Industry Analysis, Trends, Market Size & Forecasts to 2023

  • ID: 4427141
  • Report
  • Region: Global
  • 120 pages
  • Infinium Global Research
1 of 5

FEATURED COMPANIES

  • Biocon Limited
  • ELI Lilly and Company
  • Insulet Corporation
  • Medtronic PLC
  • Novo Nordisk A/S
  • Sanofi
  • MORE
The report on global Insulin delivery system market provides qualitative and quantitative analysis for the period of 2015 to 2023. The report predicts the global Insulin delivery system market to grow with a CAGR of 5.2% from 2017 to 2023. The global Insulin delivery system market was worth USD 9.72 billion in 2016.The study on Insulin delivery system market covers the analysis of regions such as Americas, Europe, Asia Pacific, and Rest of the World. Among the geographies Americas dominated the world market while as well as anticipated to grow at the highest CAGR over the forecast period.

The report on global Insulin delivery system market is a comprehensive study of demand, market size, forecasts, trends and factors affecting the global Insulin delivery system market. Moreover, the report is collective presentation of primary and secondary research findings. In addition, it provides deep insights on the factors that are driving, restraining the global Insulin delivery system market. Porter’s five forces model in the report provides insights into the competitive rivalry in the global Insulin delivery system market over the period of 2015 - 2023. Further. The growth matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology
  • Primary Research
Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents.

The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through:
1. Key Opinion Leaders associated with the author
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers

Primary research respondents typically include:
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:
  • Company reports and publications
  • Government/institutional publications
  • Trade and associations’ journals
  • Databases such as WTO, OECD, and World Bank, among others.
  • Websites and publications by research agencies
Report Findings

1. Drivers
  • Patient are moving from hospitals to speciality clinics
  • User prefer syringes and insulin pens because of their low cost
  • Refining policies for compensation, and availability
  • Affordability of devices
2. Restraints
  • Needle nervousness in patients affect the growth of the pen needles and syringes market
  • problems related with the reuse of pen needles and infusion sets
3. Opportunities
  • Growing research and development
  • Increasing expenditure in emerging economies on diabetes-related health
Segments Covered

1. Global Insulin delivery system market by Product type
a. insulin pens
b. insulin jet injectors
c. syringes
d. insulin pumps

2. Global Insulin delivery system market by End user
a. Specialty diabetic clinics
b. Hospitals
c. Retail channels transdermal

Companies Profiled:

The companies covered in the report include:
  • ELI Lilly and Company
  • Ypsomed Holding AG
  • Becton, Dickinson and Company
  • Novo Nordisk A/S
  • Tandem Diabetes Care, Inc.
  • Medtronic PLC
  • Sanofi
  • Animas Corporation (Johnson and Johnson)
  • Insulet Corporation
  • Biocon Limited
Reasons to buy this report
1. Comprehensive analysis of global as well as regional markets of Insulin delivery system
2. Complete coverage of all the product type and end user segments to analyze the trends, developments in Insulin delivery system market, and forecast of market size up to 2023.
3. Comprehensive analysis of the companies operating in Insulin delivery system market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. The Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Biocon Limited
  • ELI Lilly and Company
  • Insulet Corporation
  • Medtronic PLC
  • Novo Nordisk A/S
  • Sanofi
  • MORE
1. Preface
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches

2. Executive Summary

3. Global Insulin delivery system Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.2.4 Challenges
3.3 Porter’s Five Forces Analysis
3.4 Growth Matrix Analysis
3.5 Competitive Landscape in the Insulin delivery system Market

4. Global Insulin delivery system Market: Snapshot
4.1 Global Insulin delivery system market key trends
4.2 Global Insulin delivery system market by Product type
4.3 Global Insulin delivery system market by end user

5. Global Insulin delivery system market by Product type (USD Million) 2017-2023
5.1 Insulin pens
5.2 Insulin jet injectors
5.3 Syringes
5.4 Insulin pumps

6. Global Insulin delivery system market by End user (USD Million) 2017-2023
6.1 Specialty diabetic clinics
6.2 Hospitals
6.3 Retail channels

7. Global Insulin delivery system Market Analysis, by Region (USD Million) 2017-2023
7.1 Americas
7.1.1 Americas Insulin delivery system Market by Product type (USD Million)
7.1.2 Americas Insulin delivery system Market by End user (USD Million)
7.1.3 Americas Insulin delivery system Market by country (USD Million)
7.2 Europe
7.2.1 Europe Insulin delivery system Market by Product type (USD Million)
7.2.2 Europe Insulin delivery system Market by End user (USD Million)
7.2.3 Europe Insulin delivery system Market by country (USD Million)
7.3 Asia-Pacific
7.3.1 Asia-Pacific Insulin delivery system Market by Product type (USD Million)
7.3.2 Asia-Pacific Insulin delivery system Market by End user (USD Million)
7.3.3 Asia-Pacific Insulin delivery system Market by country (USD Million)
7.4 Rest of the World (RoW)
7.4.1 RoW Insulin delivery system Market by Product type (USD Million)
7.4.2 RoW Insulin delivery system Market by End user (USD Million)

8. Company Profiles
8.1 ELI Lilly and Company
8.2 Ypsomed Holding AG
8.3 Becton, Dickinson and Company
8.4 Novo Nordisk A/S
8.5 Tandem Diabetes Care, Inc.
8.6 Medtronic PLC
8.7 Sanofi
8.8 Animas Corporation (Johnson and Johnson)
8.9 Insulet Corporation
8.10 Biocon Limited.
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • ELI Lilly and Company
  • Ypsomed Holding AG
  • Becton, Dickinson and Company
  • Novo Nordisk A/S
  • Tandem Diabetes Care, Inc.
  • Medtronic PLC
  • Sanofi
  • Animas Corporation (Johnson and Johnson)
  • Insulet Corporation
  • Biocon Limited
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll